Does TOFACITINIB Cause Hypoacusis? 1,535 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,535 reports of Hypoacusis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.0% of all adverse event reports for TOFACITINIB.
1,535
Reports of Hypoacusis with TOFACITINIB
1.0%
of all TOFACITINIB reports
59
Deaths
172
Hospitalizations
How Dangerous Is Hypoacusis From TOFACITINIB?
Of the 1,535 reports, 59 (3.8%) resulted in death, 172 (11.2%) required hospitalization, and 4 (0.3%) were considered life-threatening.
Is Hypoacusis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,535 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Hypoacusis?
SACUBITRIL\VALSARTAN (2,345)
INSULIN GLARGINE (1,406)
APIXABAN (1,249)
PREGABALIN (1,152)
ETANERCEPT (1,109)
INSULIN LISPRO (1,100)
ADALIMUMAB (948)
LENALIDOMIDE (938)
PALBOCICLIB (890)
EVOLOCUMAB (670)
Which TOFACITINIB Alternatives Have Lower Hypoacusis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN